3q26 AML cells collected from clinical samples (n = 9) were more sensitive to HDAC suppression than were other AML subtypes (n = 28) and equally responsive to chemotherapy agents in vitro (Fig. 4C). Here, HDAC9 is linked to acute myeloid leukemia.